We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Innovative Gastroscope Enhances Imaging Capabilities

By HospiMedica International staff writers
Posted on 21 Nov 2013
Print article
Image: The tip of the Fuse 1G Gastroscope (Photo courtesy of EndoChoice).
Image: The tip of the Fuse 1G Gastroscope (Photo courtesy of EndoChoice).
A flexible endoscope with an extended 245-degree field of view facilitates diagnoses in the upper gastrointestinal (GI) tract.

The Fuse 1G Gastroscope employs Full Spectrum Endoscopy technology using two cameras, while traditional systems have just one camera. This allows observation of nearly twice as much surface area, allowing clinicians to identify adenomas or precancerous lesions in and behind the folds that occur naturally in the colon and stomach anatomy, problem areas that can easily go undetected when using traditional endoscopes. Optimal imaging is enabled using built-in light emitting diode (LED) lighting around the tip to provide illumination.

Images are displayed on three high-definition (HD) screens, allowing visualization of more of the GI tract. The system uses a FuseBox control unit with the FusePanel image management system to interface with electronic medical record (EMR) systems for tracking of patients, physician IDs, and the procedures performed. It also enables saving of every image for viewing or printing later. Images can be captured remotely or can be exported in PDF format to be used on other EMR systems. The Fuse 1G Gastroscope is a product of EndoChoice (Atlanta, GA, USA), and has been approved by the US Food and Drug Administration (FDA).

“We are 100% focused on serving the GI professionals so they can give the best possible care to their patients,” said Mark Gilreath, founder and CEO of EndoChoice. “This clearance by the FDA is yet another milestone in our efforts to make the Fuse system available to more hospitals and clinics.”

“We have a national colorectal cancer screening program in the United States wherein most people should get screened for colorectal cancer, but not all patients follow these guidelines,” said Prof. Douglas K. Rex, MD, of Indiana University (Indianapolis, USA). “The data from the Full Spectrum Endoscopy Tandem study would indicate that Fuse is a radical improvement over the tools we've used in the past to fight GI disease.”

Related Links:

EndoChoice

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Pre-Op Planning Solution
Sectra 3D Trauma

Print article

Channels

Critical Care

view channel
Image: AI could help physicians detect abnormal heart rhythms earlier (Photo courtesy of 123RF)

AI to Improved Diagnosis of Atrial Fibrillation

Abnormal heart rhythms frequently arise from—and contribute to—structural abnormalities in the heart. Atrial fibrillation is a specific type of abnormal rhythm that may not be consistently present, often... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more